Tobacco, Alcohol, Prescription Medication, and Other Substance Use Screening

The TAPS Tool, developed by a study team in the NIDA Clinical Trials Network (CTN-0059), is a 2-step screening and brief assessment approach. TAPS-1, the screening component, asks about frequency of use of tobacco, alcohol (above guideline-recommended daily limits), illicit drugs, and nonmedical use of prescription medications within the previous 12 months. If the participants reports having used one of the substances, TAPS-2 then asks more specific follow-up questions regarding use in the past 3 months